Literature DB >> 19908306

Idiopathic spinal myoclonus: a clinical and neurophysiological assessment of a movement disorder of uncertain origin.

Marcello Esposito1, Mark J Edwards, Kailash P Bhatia, Peter Brown, Carla Cordivari.   

Abstract

Spinal Myoclonus (SM) is characterized by brief and sudden movements caused by the activation of muscles belonging to adjacent spinal myotomes. Recent reports have indicated that "typical" clinical and electrophysiological features of SM can be mimicked voluntarily. A useful tool that can distinguish between organic and psychogenic jerks is the detection of a Bereitschaftspotential (BP). In this study, we looked for evidence of a BP in a cohort of patients with idiopathic SM. A clinical and neurophysiological assessment of 20 patients affected by idiopathic SM was performed. A video EEG-EMG multichannel recording was performed in each patient to detect BP. An expert neurophysiologist (PB) reviewed the BP recordings and divided them into those showing a definite, possible, and no BP. A clinical assessment of the videoed movements was performed by two neurologists expert in movement disorders (KB and MJE) who indicated if the movements were compatible with organic or psychogenic myoclonus. A definite or possible BP was recorded in 15 out of 20 patients. Clinical raters agreed in their clinical opinion on 15 patients (75%). All patients where both raters agreed the movements appeared to be organic had definite or possible BP. BP are commonly seen in patients with idiopathic SM. There is discordance between clinicians in their clinical rating of SM as organic or psychogenic, but even in those patients where movements appear clinically to be organic, a BP is commonly detected, indicating that the aetiology is psychogenic. This suggests that BP recordings are a useful adjunct to clinical assessment in the accurate diagnosis of patients with idiopathic SM. (c) 2009 Movement Disorder Society.

Entities:  

Mesh:

Year:  2009        PMID: 19908306     DOI: 10.1002/mds.22812

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

Review 1.  An update and review of the treatment of myoclonus.

Authors:  Kelly Mills; Zoltan Mari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

Review 2.  Milestones in clinical neurophysiology.

Authors:  Mark Hallett; John Rothwell
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

3.  Neuropsychiatric disorders: What do neurologists think about conversion disorder?

Authors:  Joseph H Friedman
Journal:  Nat Rev Neurol       Date:  2011-05-17       Impact factor: 42.937

4.  Spinal segmental myoclonus in both legs associated with antibodies to glycine receptors.

Authors:  Hitoki Nanaura; Hiroshi Kataoka; Takao Kiriyama; Nobuyuki Eura; Naoki Iwasa; Ryogo Shobatake; Hirosei Horikawa; Kazuma Sugie
Journal:  Neurol Clin Pract       Date:  2019-04

5.  Diagnostic agreement in patients with psychogenic movement disorders.

Authors:  Francesca Morgante; Mark J Edwards; Alberto J Espay; Alfonso Fasano; Pablo Mir; Davide Martino
Journal:  Mov Disord       Date:  2012-01-04       Impact factor: 10.338

6.  Myoclonic disorders: a practical approach for diagnosis and treatment.

Authors:  Maja Kojovic; Carla Cordivari; Kailash Bhatia
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

Review 7.  Psychogenic movement disorders.

Authors:  Francesca Morgante; Mark J Edwards; Alberto J Espay
Journal:  Continuum (Minneap Minn)       Date:  2013-10

Review 8.  Physiology-Based Treatment of Myoclonus.

Authors:  Ashley B Pena; John N Caviness
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 9.  Myoclonus: An Electrophysiological Diagnosis.

Authors:  Shabbir Hussain I Merchant; Felipe Vial-Undurraga; Giorgio Leodori; Jay A van Gerpen; Mark Hallett
Journal:  Mov Disord Clin Pract       Date:  2020-06-17

Review 10.  Propriospinal myoclonus: clinical reappraisal and review of literature.

Authors:  Sandra M A van der Salm; Roberto Erro; Carla Cordivari; Mark J Edwards; Johannes H T M Koelman; Tom van den Ende; Kailash P Bhatia; Anne-Fleur van Rootselaar; Peter Brown; Marina A J Tijssen
Journal:  Neurology       Date:  2014-10-10       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.